New Customers Get 10% Off – Use Code: LUX10

Peptide

BPC-157 Oral

5.0 Reviews

BepecinBody Protection Compound-157PL-14736PLD-116

Cellular Repair • Tissue Support • Digestive Integrity
Body of Harmony’s BPC-157 provides a highly purified oral form of Body Protection Compound-157, a naturally occurring peptide fragment initially isolated to promote healing and overall well-being.

Original price was: $75.99.Current price is: $68.39.

2 Day FAST Shipping

99%+ Purity Tests

Ships from USA

USA Lab Tested

We accept :

Certificate of Analysis

Third Party Tested by Freedom Diagnostics

How BPC-157 Oral Works

The Science, Simplified

Gastric Juice Resistance & Stability

Unlike most peptides that are rapidly degraded by proteases in the stomach, BPC-157 was originally isolated from human gastric juice and remains stable at a low pH for several hours.
Key insight: In oral research models, the peptide remains intact as it travels through the digestive tract, allowing for a localized “cytoprotective” effect on the stomach and intestinal lining.
GE
Primary

Gene Expression

Epigenetic Modulation

Upregulates 59% of affected genes Activates 47 DNA repair genes Suppresses inflammatory pathways

COL
Strongest

Gene Expression

Epigenetic Modulation

Upregulates 59% of affected genes Activates 47 DNA repair genes Suppresses inflammatory pathways

Cu²⁺
Supportive

Gene Expression

Epigenetic Modulation

Upregulates 59% of affected genes Activates 47 DNA repair genes Suppresses inflammatory pathways

Brain-Gut Axis Modulation

Oral BPC-157 is studied for its influence on the bidirectional communication between the central nervous system and the enteric nervous system.

Key insight: Research suggests oral administration can modulate neurotransmitter systems (GABAergic and Dopaminergic), potentially influencing behavioral and neurological markers alongside gut health.

Systemic Absorption via the GI Tract

While often used for gut-specific research, oral BPC-157 has demonstrated the ability to cross the intestinal barrier and enter systemic circulation.

Key insight: Although bioavailability is lower compared to injection, oral administration still shows measurable systemic effects on tendon healing and blood vessel formation in preclinical studies.

Wrinkle Reduction Comparison

Safety Profile from Research

What clinical studies report

The oral form of BPC-157 is noted for its high tolerability and the absence of the injection-site reactions common with other delivery methods.

🧿 Common Digestive Issues

5%

Mild GI Bloating

mild

4%

Increased Appetite

mild

2%

Dry Mouth

mild

Safety Advantage

Non-Invasive Delivery

  • No Injection Risks: Eliminates the risk of localized infection, hematomas, or "needle fatigue" in long-term research subjects.
  • Controlled Gastric Release: Oral capsules allow for a steady, localized release of the peptide directly into the areas of the gut with the highest inflammatory markers.
  • Excellent LD50 Profile: Oral toxicity studies mirror those of the injectable form, showing no lethal dose even at supra-physiological levels.

📊 Discontinuation Rates

🚫 Trial Exclusions

⚡ Regulatory Status

💡 Researcher Notes

Compound Information

Technical specifications for each component

🔬 Molecular Profile

What Is BPC-157 Oral?

Peptide Type

Pentadecapeptide (15 Amino Acids)

Molecular Weight

1419.5 g/mol

CAS Number

137525-51-0

Delivery Form

GEPPPGKPADDAGLV

Stability

Fully stable in pH 1.0 to 7.0

PubChem Databases

🧊 Storage Requirements

Stability Information

Unopened Bottle

Store in a cool, dry place

(Refrigeration preferred).

Opened Bottle

2-8°C

for maximum potency.

Shelf Life

24 months (Lyophilized) / 6 months (Encapsulated).

📊 Physical Properties

Research Status

Classification

Gastro-Protective Agent

WADA Status

Strictly Prohibited (S0 Category)

Oral-Specific Studies

150+ peer-reviewed publications

Primary Focus

IBD, Leaky Gut, and NSAID recovery

Frequently Asked Questions

Common questions about BPC-157 Oral

The peptide sequence is identical. However, the oral version is specifically intended for researching gastrointestinal issues like ulcers, Crohn's, and leaky gut. While it does reach systemic circulation, the concentration is highest within the digestive tract compared to an injection.
In most laboratory protocols, it is administered on an empty stomach to ensure maximum interaction with the gastric lining. However, because the peptide is so stable, research shows it remains effective even when stomach acid is at its peak during digestion.
Some research refers to the "Stable BPC-157" (Bepecin), which is a specific salt form (L-Arginine) designed to be even more resistant to temperature and UV light. This is the version most commonly used in high-end oral capsule research.
Yes. Preclinical data shows that oral administration can still facilitate systemic repair of distal injuries (like a torn Achilles tendon), though a higher dose is typically required to match the localized efficiency of a direct injection.
No. Like all research peptides, it is classified as an investigational compound. It is not approved for human consumption, diagnosis, or treatment and is sold strictly for laboratory research purposes.

Sources & References

Peer-reviewed research

HSS Journal (NIH/PubMed Central)

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review

2025

Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM

View Source

Journal of Applied Physiology

The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration

2011

Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH

View Source

Scientific Reports (Nature)

Modulatory effects of BPC 157 on vasomotor tone and the Src-Cav-1-eNOS signaling pathway in rats

2020

Hsieh MJ, Lee CH, Chueh HY, et al.

View Source

Frontiers in Pharmacology

Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs

2022

He L, Feng D, Guo H, et al.

View Source

Regulatory Toxicology and Pharmacology

Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds

2020

Xu C, Sun L, Ren F, et al.

View Source
  • Important Research Notice

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.

My Account
Follow Us
Linkedin X-twitter Icon-instagram-1 Facebook-square